This section keeps you up-to-date on the latest news and upcoming public appearances of Lavery professionals.
News
-
Lavery assists Fancamp Exploration Ltd. in a joint venture agreement with Platinex Inc.
On March 13, 2023, Fancamp Exploration Ltd. (Fancamp) officially announced that it had entered into a joint venture agreement with Platinex Inc. (Platinex) to further explore and promote certain gold mining properties located in Ontario and owned by the two entities. The transaction involved Fancamp transferring its Heenan Mallard and Dorothy mining properties to South Timmins Mining Inc. (Goldco), a wholly-owned subsidiary of Platinex, in exchange for shares representing 25% of Goldco's issued and outstanding shares and a 1% royalty on the properties to Platinex. The transaction also included a shareholder agreement providing for the governance of Goldco's activities. Fancamp subscribed for a number of shares representing 9.5% of Platinex's issued and outstanding shares. Lavery was privileged to represent Fancamp in this important mandate led by Jean-Paul Timothée and Alexandre Turcotte. -- Fancamp is a growing Canadian mineral exploration corporation dedicated to its value-added strategy of advancing its priority mineral properties through exploration and innovative development. The corporation owns numerous mineral resource properties in Quebec, Ontario and New Brunswick, where it mines chromium sector, strategic rare-earth metals, gold, zinc, titanium and other resources. To learn more about Fancamp, go to: https://www.fancamp.ca
-
Lavery represents ImmunoPrecise Antibodies as it acquires BioStrand
On March 29, 2022, ImmunoPrecise Antibodies Ltd (IPA) announced that it acquired BioStrand BV, BioKey BV, and BioClue BV (together, “BioStrand”), a group of Belgian entities pioneers in the field of bioinformatics and biotechnology. With this €20 million acquisition, IPA will be able to leverage BioStrand’s revolutionary AI-powered methodology to accelerate the development of therapeutic antibody solutions. In addition to creating synergies with its subsidiaries, IPA expects to develop new markets with this revolutionary technology and strengthen its position as a world leader in biotherapeutics. Lavery was privileged to support IPA in this cross-border transaction by providing specialized expertise in cybersecurity, intellectual property, securities and mergers and acquisitions. The Lavery team was led by Selena Lu (transactional) and included Eric Lavallée (technology and intellectual property), Serge Shahinian (intellectual property), Sébastien Vézina (securities), Catherine Méthot (transactional), Jean-Paul Timothée (securities and transactional), Siddhartha Borissov-Beausoleil (transactional), Mylène Vallières (securities) and Marie-Claude Côté (securities). ImmunoPrecise Antibodies Ltd. is a biotherapeutic, innovation-powered company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of target classes and diseases.
-
Lavery represents Evolution Insurance in its merger with GroupAssur
On April 20, 2021, GroupAssur, a managing general agent (MGA) offering specialty insurance products across Canada, announced its merger with our client Evolution Insurance, a wholesaler specializing in the underwriting of complex liability and construction risks. The merger makes GroupAssur Canada’s largest independent managing general agent in property and casualty insurance. Evolution Insurance’s expertise will enable GroupAssur to expand its product offering into target markets across Canada. A Lavery team led by Martin Pichette and Sébastien Vézina and composed of Jean-Paul Timothée, Gabriella Settino, Isabelle Normand and Florence Fournier (transactional) and Ali El Haskouri, Bernard Trang and Ana Nascimento (financing) played a significant role in representing Evolution Insurance’s interests throughout the transaction.